|
| |
| | 62341 | | 01.05.2012 | | Sanofi-Aventis (Suisse) SA | | | | | | | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
---|
01 | Caprelsa 100 mg | comprimés pelliculés | Coated tablets (Vandetanibum 100 mg) | L01EX04 | CI | 02 | Caprelsa 300 mg | comprimés pelliculés | Coated tablets (Vandetanibum 300 mg) | L01EX04 | CI |
|
|
|